OSHA SearchOSHA records by employer

Excite Pharma Services LLC: OSHA inspections and violations

Lees Summit, Missouri · Pharmaceutical Preparation Manufacturing · NAICS 325412

2inspections
7citation items
$9,374current penalties
Dec 7, 2022last inspection

Excite Pharma Services LLC has 2 OSHA inspections on record in Missouri, the first in 2022.

OSHA's last visit started on Dec 7, 2022 after a complaint, in Lees Summit.

Across those inspections OSHA issued 7 citation items: 7 serious.

OSHA proposed $15,624 in penalties. After settlements and reviews the total is $9,374, down 40%.

Most often, OSHA cited 1910.134, respiratory protection (4 items).

For context, across all manufacturing employers the median penalty per cited inspection since 2015 is $4,500. Excite Pharma Services LLC averages $4,687 over 2 cited inspections in that time.

Excite Pharma Services LLC: OSHA citation items per year, 2022 to 2022
Citation items per year, by inspection date.

Missouri · latest 90 days of OSHA records

121employers cited

Get notified the morning OSHA posts each new citation in Missouri: the employer, the site address, the rules broken and the penalty.

See who gets cited next

Latest cited in Missouri

Checking a subcontractor, a client or your own company? Watch Excite Pharma Services LLC and get notified the morning OSHA posts a new citation for it.

Watch this company

Inspection history

Inspection 346377856 OPENED DEC 7, 2022Closed

Complaint · Partial · Health · 15 employees at the site · Closed Jul 25, 2023

1260 Nw Main Street, Lees Summit, MO 64086 · Pharmaceutical Preparation Manufacturing · OSHA's record · Phone and website on Google Maps

Citation and ruleTypeProposedCurrentIssuedStatus
Citation 1, item 1a
29 CFR 1910.134(e)(1) · Respiratory protection
 Serious$4,687$2,812May 1, 2023Final
Citation 1, item 1b
29 CFR 1910.134(f)(1) · Respiratory protection
 Serious$0$0May 1, 2023Final
Citation 1, item 1c
29 CFR 1910.134(g)(1)(i)(a) · Respiratory protection
 Serious$0$0May 1, 2023Final
Citation 1, item 1d
29 CFR 1910.134(h)(2)(i) · Respiratory protection
 Serious$0$0May 1, 2023Final
Citation 1, item 2
29 CFR 1910.151(c) · First aid and eyewash
 Serious$6,250$3,750May 1, 2023Final

Inspection 346377880 OPENED DEC 7, 2022Closed

Complaint · Partial · Safety · 15 employees at the site · Closed Jun 9, 2023

1260 Nw Main Street, Lees Summit, MO 64086 · Pharmaceutical Preparation Manufacturing · OSHA's record · Phone and website on Google Maps

Citation and ruleTypeProposedCurrentIssuedStatus
Citation 1, item 1a
29 CFR 1910.178(l)(2)(ii) · Forklifts and other powered industrial trucks
 Serious$4,687$2,812Apr 28, 2023Final
Citation 1, item 1b
29 CFR 1910.178(l)(6) · Forklifts and other powered industrial trucks
 Serious$0$0Apr 28, 2023Final

The rules behind these citations

Current text from the Code of Federal Regulations. Some citations were issued under older wording.

29 CFR 1910.134 · Respiratory protection

29 CFR 1910.134(e)(1)

(1) General. The employer shall provide a medical evaluation to determine the employee's ability to use a respirator, before the employee is fit tested or required to use the respirator in the workplace. The employer may discontinue an employee's medical evaluations when the employee is no longer required to use a respirator.

29 CFR 1910.134(f)(1)

(1) Normal breathing. In a normal standing position, without talking, the subject shall breathe normally.

29 CFR 1910.134(g)(1)(i)(a)

(A) Facial hair that comes between the sealing surface of the facepiece and the face or that interferes with valve function; or

29 CFR 1910.151 · First aid and eyewash

29 CFR 1910.178 · Forklifts and other powered industrial trucks

Other pharmaceutical preparation manufacturing employers in Missouri

Alert subscribers get notified of each newly cited employer in Missouri the morning it is posted. See the alert plans.

Source: U.S. Department of Labor, OSHA enforcement data. A citation is OSHA's allegation; employers can contest it, and the status column shows where each item stands. Something wrong on this page? Tell us.